The passage of the Life Sciences bill in the Commonwealth holds great promise for important research into diseases that impact lives, like Type 1 diabetes that James S. Hirsch wrote about:
.
“We are pleased to see that Governor Patrick has been awarded with this well-deserved recognition – and to watch his efforts coming to fruition” with the passage of the life-sciences bill, McKay said.
“Organogenesis is a spin-off of technology developed at MIT,” he noted, “and our living cell therapies have helped to treat hundreds of thousands of patients around the world. We have spent an incredible amount of time, energy and funds to pioneer the regenerative-medicine industry, including the industry’s first-ever FDA approvals.”
When “we had outgrown our existing facilities, and were ready to make a commitment to a major expansion,” McKay added, “Governor Patrick was a major catalyst for Organogenesis’ decision to remain and expand in Massachusetts – and he in fact helped reverse our decision to leave the state.
“The life-sciences bill solidified the state of Massachusetts as the best place in the world to translate potentially life-saving research into viable, successful businesses,” he said.
No comments:
Post a Comment